THWART Trademark

Trademark Overview

On Friday, November 9, 2018, a trademark application was filed for THWART with the United States Patent and Trademark Office. The USPTO has given the THWART trademark a serial number of 88187809. The federal status of this trademark filing is REGISTERED as of Tuesday, June 16, 2020. This trademark is owned by Aclaris Therapeutics, Inc.. The THWART trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research and testing in the field of dermatology; providing medical research and scientific research information in the field of dermatology and clinical trials; scientific investigations for medical purposes featuring clinical trials
thwart

General Information

Serial Number88187809
Word MarkTHWART
Filing DateFriday, November 9, 2018
Status700 - REGISTERED
Status DateTuesday, June 16, 2020
Registration Number6081017
Registration DateTuesday, June 16, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 1, 2019

Trademark Statements

Goods and ServicesMedical and scientific research and testing in the field of dermatology; providing medical research and scientific research information in the field of dermatology and clinical trials; scientific investigations for medical purposes featuring clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, November 27, 2018
Primary Code042
First Use Anywhere DateSaturday, September 15, 2018
First Use In Commerce DateSaturday, September 15, 2018

Trademark Owner History

Party NameAclaris Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWayne, PA 19087
Party NameAclaris Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWayne, PA 19087
Party NameAclaris Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWayne, PA 19087

Trademark Events

Event DateEvent Description
Tuesday, December 4, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 13, 2018NEW APPLICATION ENTERED
Tuesday, November 27, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 4, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 14, 2019ASSIGNED TO EXAMINER
Thursday, February 21, 2019NON-FINAL ACTION WRITTEN
Thursday, February 21, 2019NON-FINAL ACTION E-MAILED
Thursday, February 21, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 7, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 7, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 7, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 22, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 29, 2019ASSIGNED TO LIE
Wednesday, September 11, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 1, 2019PUBLISHED FOR OPPOSITION
Tuesday, October 1, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 26, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 11, 2019TEAS STATEMENT OF USE RECEIVED
Wednesday, December 11, 2019USE AMENDMENT FILED
Tuesday, December 17, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 18, 2019STATEMENT OF USE PROCESSING COMPLETE
Tuesday, April 14, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 14, 2020SU - NON-FINAL ACTION - WRITTEN
Tuesday, January 14, 2020NON-FINAL ACTION E-MAILED
Tuesday, January 14, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 15, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 15, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, May 9, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, June 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 8, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, June 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 1, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 1, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 1, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, June 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 16, 2020REGISTERED-PRINCIPAL REGISTER
Thursday, November 2, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, November 2, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 16, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, November 2, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, November 2, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 2, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Related Keywords

thwart medical research scientific clinical trials field dermatology featuring purposes investigations